Public Employees Retirement System of Ohio Invests $2.25 Million in Omnicell, Inc. $OMCL

Public Employees Retirement System of Ohio purchased a new stake in Omnicell, Inc. (NASDAQ:OMCL) during the 2nd quarter, HoldingsChannel reports. The fund purchased 54,273 shares of the company’s stock, valued at approximately $2,253,000.

Other large investors have also recently bought and sold shares of the company. Versant Capital Management Inc raised its stake in Omnicell by 38.7% during the second quarter. Versant Capital Management Inc now owns 1,053 shares of the company’s stock worth $44,000 after acquiring an additional 294 shares in the last quarter. Cerity Partners LLC increased its position in shares of Omnicell by 4.9% during the 4th quarter. Cerity Partners LLC now owns 7,613 shares of the company’s stock worth $345,000 after purchasing an additional 354 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in Omnicell by 1.2% during the 2nd quarter. Thrivent Financial for Lutherans now owns 34,445 shares of the company’s stock valued at $1,013,000 after purchasing an additional 424 shares during the last quarter. Legal & General Group Plc boosted its position in Omnicell by 0.3% in the third quarter. Legal & General Group Plc now owns 158,399 shares of the company’s stock valued at $4,823,000 after buying an additional 448 shares in the last quarter. Finally, California State Teachers Retirement System grew its stake in Omnicell by 1.7% during the second quarter. California State Teachers Retirement System now owns 42,552 shares of the company’s stock worth $1,251,000 after buying an additional 692 shares during the last quarter. 97.70% of the stock is currently owned by institutional investors.

Omnicell Stock Down 1.3%

Shares of OMCL opened at $34.37 on Friday. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of 40.92, a PEG ratio of 0.86 and a beta of 0.97. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.43 and a current ratio of 1.64. The business’s fifty day moving average price is $39.34 and its two-hundred day moving average price is $39.24. Omnicell, Inc. has a 52 week low of $29.06 and a 52 week high of $55.00.

Omnicell (NASDAQ:OMCL) last released its earnings results on Thursday, July 30th. The company reported $0.94 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.47. Omnicell had a return on equity of 5.66% and a net margin of 3.13%.The company had revenue of $312.21 million during the quarter, compared to the consensus estimate of $310.21 million. During the same quarter in the previous year, the company posted $0.45 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. Omnicell has set its Q3 2026 guidance at 0.350-0.430 EPS and its FY 2026 guidance at 2.150-2.300 EPS. On average, analysts predict that Omnicell, Inc. will post 1.41 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on OMCL. Piper Sandler reiterated an “overweight” rating and issued a $45.00 target price (down from $55.00) on shares of Omnicell in a research note on Monday, August 3rd. Weiss Ratings upgraded Omnicell from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 18th. Wells Fargo & Company decreased their target price on Omnicell from $55.00 to $50.00 and set an “overweight” rating on the stock in a report on Friday, July 31st. Wall Street Zen raised Omnicell from a “buy” rating to a “strong-buy” rating in a report on Sunday, May 10th. Finally, KeyCorp reiterated an “overweight” rating on shares of Omnicell in a research report on Monday, August 24th. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Omnicell currently has a consensus rating of “Moderate Buy” and an average price target of $57.86.

Omnicell Profile

Omnicell, Inc is a healthcare technology company that specializes in medication management solutions for hospitals, clinics and pharmacies. The company’s offerings encompass automated dispensing cabinets, pharmacy automation systems, IV compounding devices, and software platforms designed to optimize medication usage, streamline workflow and improve patient safety. Omnicell’s analytics and inventory management tools provide real-time visibility into medication utilization, helping healthcare providers reduce waste, manage controlled substances and ensure regulatory compliance.

Founded in Mountain View, California in 1992, Omnicell has grown through both internal innovation and strategic acquisitions to broaden its portfolio across the medication management continuum.